Trials / Unknown
UnknownNCT05274893
A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer
A Randomized, Open-label, Two-cycle Crossover Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, open-label, pharmacokinetic comparison study of SYHX2011 and Abraxane® in patients with advanced breast cancers after single IV infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYHX2011 and Abraxane® | IV infusion, 260 mg/m\^2 |
Timeline
- Start date
- 2022-03-31
- Primary completion
- 2022-09-30
- Completion
- 2022-10-30
- First posted
- 2022-03-11
- Last updated
- 2022-03-11
Source: ClinicalTrials.gov record NCT05274893. Inclusion in this directory is not an endorsement.